Aura Biosciences medical chief sells 16,903 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Aura Biosciences, Inc. Chief Medical Officer Janet Jill Hopkins sold 16,903 common shares on November 16, 2026, at a weighted average price of $7.05 per share; individual sales ranged from $7.05 to $7.0584. The automatic sales covered tax withholding obligations connected with vesting of restricted stock units and were not at her discretion. She directly held 363,287 shares after the sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 16,903 | $7.05 | $119K |
Footnotes (2)
- F1. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
- F2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.05 to $7.0584 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
weighted average price financial
restricted stock units financial
tax withholding obligations financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.